Transforming Growth Factor-β Stimulates the Production of Osteoprotegerin/Osteoclastogenesis Inhibitory Factor by Bone Marrow Stromal Cells

Cited by (299)

Items 101–200 of 299

1. Transforming Growth Factor-β-induced Osteoblast Elongation Regulates Osteoclastic Bone Resorption through a p38 Mitogen-activated Protein Kinase- and Matrix Metalloproteinase-dependent Pathway
   Karsdal, Morten A., Fjording, Marianne S., Foged, Niels T., Delaissé, Jean-Marie, Lochter, André · 2001 · Journal of Biological Chemistry
2. The coding polymorphism T263I in TGF-β1 is associated with otosclerosis in two independent populations
   Melissa Thys, Isabelle Schrauwen, Kathleen Vanderstraeten, Katrien Janssens, Nele Dieltjens, Kris Van Den Bogaert, Erik Fransén, Wenjie Chen, Megan Ealy, Mireille Claustres et al. · 2007 · Human Molecular Genetics
3. Reciprocal Control of Expression of mRNAs for Osteoclast Differentiation Factor and OPG in Osteogenic Stromal Cells by Genistein: Evidence for the Involvement of Topoisomerase II in Osteoclastogenesis
   Takumi Yamagishi, Eri Otsuka, Hiromi Hagiwara · 2001 · Endocrinology
4. Transforming Growth Factor-β1 (TGF-β1) Induces Human Osteoclast Apoptosis by Up-regulating Bim
   Houde, Nicolas, Chamoux, Estelle, Bisson, Martine, Roux, Sophie · 2009 · Journal of Biological Chemistry
5. 1α,25 Dihydroxyvitamin D3 Rapidly Regulates the Mouse Osteoprotegerin Gene Through Dual Pathways
   Takeshi Kondo, Riko Kitazawa, Sakan Maeda, Sohei Kitazawa · 2004 · Journal of Bone and Mineral Research
6. Elevated levels of osteoprotegerin (OPG) and hepatocyte growth factor (HGF) in rheumatoid arthritis
   A. J. Feuerherm, M. Børset, C. Seid · 2001 · Scandinavian Journal of Rheumatology
7. Combined use of insulin and endothelin-1 causes decrease of protein expression of ?-subunit of insulin receptor, insulin receptor substrate-1, and insulin-stimulated glucose uptake in rat adipocytes
   Kuang‐Chung Shih, Ching‐Fai Kwok, Low-Tone Ho · 2000 · Journal of Cellular Biochemistry
8. Identification of RANKL in Osteolytic Lesions of the Facial Skeleton
   Jessica Tay, Boon‐Huat Bay, J.F Yeo, Malcolm Harris, S Meghji, Shaikali Thameem Dheen · 2004 · Journal of Dental Research
9. Molecular genetics of too much bone
   Katrien Janssens · 2002 · Human Molecular Genetics
10. (Pre-)Osteoclasts Induce Retraction of Osteoblasts Before Their Fusion to Osteoclasts
    Perez-Amodio, S, Beertsen, W, Everts, V · 2004 · Journal of Bone and Mineral Research
11. The effect of environmental cues on the differentiation of myofibroblasts in peritoneal granulation tissue
    2000
12. MOTS-c inhibits Osteolysis in the Mouse Calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation
    Yan Zhao, Shu Zhu, Hanli Wang, Li Wang, Tianshu Du, Zichen Ye, Dongsheng Zhai, Zheng Gang Zhu, Xiaoxi Tian, Zifan Lu et al. · 2019 · Pharmacological Research
13. Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells
    Michiko Kanzawa, Takeshi Sugimoto, Masanori Kanatani, Kazuo Chihara · 2000 · European Journal of Endocrinology
14. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis
    Shugo Yamashita, Hidemasa Katsumi, Nozomi Hibino, Yugo Isobe, Yumiko Yagi, Yuka Tanaka, Saki Yamada, Chihiro Naito, Akira Yamamoto · 2017 · Biomaterials
15. Basic fibroblast growth factor induces osteoclast formation by reciprocally regulating the production of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in mouse osteoblastic cells.
    Nakagawa, Nobuaki, Yasuda, Hisataka, Yano, Kazuki, Mochizuki, Shin-ichi, Kobayashi, Naoki, Fujimoto, Hitoshi, Shima, Nobuyuki, Morinaga, Tomonori, Chikazu, Daichi, Kawaguchi, Hiroshi et al. · 1999 · Biochemical and Biophysical Research Communications
16. Megakaryocyte population in human bone marrow increases with estrogen treatment: a role in bone remodeling?
    Sharyn Bord, Shobna Vedi, S.R Beavan, Angela M. Horner, Juliet Elizabeth Compston · 2000 · Bone
17. Osteoclast formation and bone resorption are inhibited by megakaryocytes
    Beeton, C.A., Bord, S., Ireland, D., Compston, J.E. · 2006 · Bone
18. Osteoclastogenesis and arthritis
    Nicola Maruotti, Maria Grano, Silvia Concetta Colucci, Francesca Donofrıo, Francesco Paolo Cantatore · 2010 · Clinical and Experimental Medicine
19. The Influence of Weight Loss on Serum Osteoprotegerin Concentration in Obese Perimenopausal Women
    Michał Tadeusz Holecki, Barbara Zahorska‐Markiewicz, Joanna Janowska, Teresa Nieszporek, Katarzyna Wojaczyńska‐Stanek, Agnieszka Żak‐Gołąb, Andrzej Więcek · 2007 · Obesity
20. Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases
    A Sabokbar, David J. Mahoney, F. Hemingway, Nicholas A Athanasou · 2015 · Clinical Reviews in Allergy & Immunology
21. Cytokines and Bone Remodeling
    Gregory R. Mundy, Babatunde O. Oyajobi, Gloria E. Gutierrez, Julie A. Rhoades Sterling, Susan S. Padalecki, Florent Elefteriou, Ming Zhao · 2008 · Elsevier eBooks
22. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement
    Germán Barbieri, Patricia Solano, José Antonio Alarcón, Rolando Vernal, María Judith Ríos-Lugo, Mariano Sanz, Conchita Martín · 2012 · The Angle Orthodontist
23. Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men
    Yoshiji Yamada · 2003 · Molecular Genetics and Metabolism
24. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression
    Zhijun Zhao, Xiaodong Hou, Xiaoxiang Yin, Yanyun Li, Rong Duan, Brendan F. Boyce, Zhenqiang Yao · 2015 · PLoS ONE
25. The osteoimmunology of alveolar bone loss
    Kevin A. Tompkins · 2016 · Connective Tissue Research
26. Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis
    Brad N. Bolon, Victoria Shalhoub, Paul J. Kostenuik, Giuseppe Campagnuolo, Sean Morony, William J. Boyle, Debra Jeske Zack, Ulrich Feige · 2002 · Arthritis & Rheumatism
27. The Smads: transcriptional regulation and mouse models
    Michael Datto, X.-F. Wang · 2000 · Cytokine & Growth Factor Reviews
28. Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer
    Colby L. Eaton, Jason M. Wells, Ingunn Holen, Peter Ian Croucher, Freddie Charles Hamdy · 2004 · The Prostate
29. The generation of highly enriched osteoclast-lineage cell populations
    Julian M.W. Quinn, Genevieve A. Whitty, Robert J. Byrne, Matthew T. Gillespie, John A. Hamilton · 2002 · Bone
30. The potential role of bisphosphonates in prostate cancer
    Grenville M. Oades, Jonathan P. Coxon, Kay W. Colston · 2002 · Prostate Cancer and Prostatic Diseases
31. Smad-dependent mechanisms of inflammatory bone destruction
    Michelle Fennen, Thomas Pap, Berno Dankbar · 2016 · Arthritis Research & Therapy
32. The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis
    Wessam E. Sharaf‐Eldin, Nourhan Abu-Shahba, Marwa Mahmoud, Nagwa El‐Badri · 2015 · Stem Cells International
33. The role of dental pulp cells in resorption of deciduous teeth
    Sibel Yıldırım, M. Yapar, U. Sermet, Kenan Şener, Ayhan Kubar · 2007 · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
34. Overexpression of γ-Glutamyltransferase in Transgenic Mice Accelerates Bone Resorption and Causes Osteoporosis
    Kiyoshi Hiramatsu, Yutaro Asaba, Sunao Takeshita, Yuji Nimura, Sawako Tatsumi, Nobuyoshi Katagiri, Shumpei Niida, Toshihiro Nakajima, Sakae Tanaka, Masako Ito et al. · 2007 · Endocrinology
35. Effect of IL‐1β, PGE2, and TGF‐β1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts
    Susana Jurado, Natalia García‐Giralt, Adolfo Díez‐Pérez, Pedro Esbrit, Guy Yoskovitz, Lídia Águeda, Roser Urreizti, Lluís Pérez-Edo, Guillem Saló, Leonardo Mellibovsky et al. · 2010 · Journal of Cellular Biochemistry
36. Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact
    Penny E Reid, Nicola Jane Brown, Ingunn Holen · 2009 · Molecular Cancer
37. Effect of TGF-β1 Stimulation on the Secretome of Human Adipose-Derived Mesenchymal Stromal Cells
    Tania M. Rodríguez, Alejandro José Saldías, Marcelo Irigo, Jorge Velasco Zamora, Marcelo Javier Perone, Ricardo A. Dewey · 2015 · Stem Cells Translational Medicine
38. NF-κB Decoy Oligodeoxynucleotide Enhanced Osteogenesis in Mesenchymal Stem Cells Exposed to Polyethylene Particle
    Tzu‐Hua Lin, Taishi Sato, Katherine R Barcay, Heather Waters, Florence Loi, Ruth Zhang, Jukka Pajarinen, Kensuke Egashira, Zhenyu Yao, Stuart Barry Goodman · 2014 · Tissue Engineering Part A
39. Osteoinmunología: el estudio de la relación entre el sistema inmune y el tejido óseo
    Luis R. Arboleya, Santos Castañeda · 2013 · Reumatología Clínica
40. Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro
    Tomoka Hasegawa, Takashi Kikuiri, Sadaaki Takeyama, Yoshitaka Yoshimura, Masato Mitome, Haruhisa Oguchi, Tetsuo Shirakawa · 2002 · Tissue and Cell
41. Osteoimmunology: The Study of the Relationship Between the Immune System and Bone Tissue
    Luis R. Arboleya, Santos Castañeda · 2013 · Reumatología Clínica (English Edition)
42. Association of a Leu10→Pro polymorphism of the transforming growth factor-β1 with genetic susceptibility to osteoporosis and spinal osteoarthritis
    Yoshiji Yamada · 2000 · Mechanisms of Ageing and Development
43. The TNF Receptor Superfamily: Role in Immune Inflammation and Bone Formation
    Xin Cheng, Masa Kinosaki, Ramachandran Murali, Mark Irwin Greene · 2003 · Immunologic Research
44. A Mutation Affecting the Latency-Associated Peptide of TGFβ1 in Camurati-Engelmann Disease Enhances Osteoclast Formationin Vitro
    Neil W. A. McGowan, Heather K. Macpherson, Katrien Janssens, Wim Van Hul, Julie C. Frith, William Duncan Fraser, Stuart H. Ralston, Miep Helfrich · 2003 · The Journal of Clinical Endocrinology & Metabolism
45. Platelet‐rich plasma impairs osteoclast generation from human precursors of peripheral blood
    E. Cenni, Sofia Avnet, Caterina Fotia, Manuela Salerno, Nicola Baldini · 2010 · Journal of Orthopaedic Research®
46. RANKL-Independent Osteoclastogenesis: A Long-Standing Controversy
    Sakae Tanaka · 2016 · Journal of Bone and Mineral Research
47. Estrogens and Progestins
    Russell T. Turner, David J. Rickard, Urszula T. Iwaniec, Thomas C. Spelsberg · 2008 · Elsevier eBooks
48. RANK(L) as a Key Target for Controlling Bone Loss
    Andreas Leibbrandt, Josef Martin Penninger · 2009 · Advances in experimental medicine and biology
49. Expression of osteoprotegerin mRNA and protein in murine megakaryocytes
    Hédia Chagraoui, Siham Sabri, Claude Capron, Jean‐Luc Villeval, William Vainchenker, Françoise Wendling · 2003 · Experimental Hematology
50. Anabolic effects of a G protein–coupled receptor kinase inhibitor expressed in osteoblasts
    Robert F. Spurney, Patrick J. Flannery, Sanford C. Garner, Krairerk Athirakul, Shiguang Liu, Farshid Guilak, L. Darryl Quarles · 2002 · Journal of Clinical Investigation
51. Tumor Necrosis Factor-α Alters the Modulatory Effects of Mesenchymal Stem Cells on Osteoclast Formation and Function
    Heng Zhu, Xiao-Xia Jiang, Zi-Kuan Guo, Hong Li, Yong-Feng Su, Huiyu Yao, Xiao-Yan Wang, Xiu-Sen Li, Ying Wu, Yuan-Lin Liu et al. · 2009 · Stem Cells and Development
52. Apoptosis in Bone Cells
    Brendan F. Boyce, David Emlyn Hughes, K. R. Wright, Lianping Xing, Aihua Dai · 1998 · Springer eBooks
53. Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells
    Tomoko Okada, Shingo Akikusa, Hiroaki Okuno, Masato Kodaka · 2003 · Clinical & Experimental Metastasis
54. Advanced Glycation End Product 3 (AGE3) Increases Apoptosis and the Expression of Sclerostin by Stimulating TGF-β Expression and Secretion in Osteocyte-Like MLO-Y4-A2 Cells
    Masakazu Notsu, Ippei Kanazawa, Ayumu Takeno, Maki Yokomoto‐Umakoshi, Ken‐ichiro Tanaka, Toru Yamaguchi, Toshitsugu Sugimoto · 2017 · Calcified Tissue International
55. TGFβ1 Regulates Human RANKL-Induced Osteoclastogenesis via Suppression of NFATc1 Expression
    Tadahiro Tokunaga, Sho Mokuda, Hiroki Kohno, Kazutoshi Yukawa, Tatsuomi Kuranobu, Katsuhiro Oi, Yusuke Yoshida, Shintaro Hirata, Eiji Sugiyama · 2020 · International Journal of Molecular Sciences
56. Nitrogen-containing bisphosphonate, YM529/ONO-5920 (a novel minodronic acid), inhibits RANKL expression in a cultured bone marrow stromal cell line ST2
    Shozo Nishida, Masanobu Tsubaki, Mayumi Hoshino, Ayumi Namimatsu, Hiromi Uji, Shohei Yoshioka, Yoshihiro Tanimori, Masashi Yanae, Masahiro Iwaki, Kiyohiro Irimajiri · 2005 · Biochemical and Biophysical Research Communications
57. Endothelial cells incubated with platelet‐rich plasma express PDGF‐B and ICAM‐1 and induce bone marrow stromal cell migration
    E. Cenni, Gabriela Ciapetti, Donatella Granchi, Caterina Fotia, Francesca Perut, Armando Giunti, Nicola Baldini · 2009 · Journal of Orthopaedic Research®
58. Transforming Growth Factor-β
    Sarah L. Dallas, Tamara N. Alliston, Lynda Faye Bonewald · 2008 · Elsevier eBooks
59. Novel and Selective Small Molecule Stimulators of Osteoprotegerin Expression Inhibit Bone Resorption
    Jude E. Onyia, Rachelle J. Sells Galvin, Yanfei Li, David Halladay, Rebecca R. Miles, Xuhao Yang, Tina R. Fuson, Ricky L. Cain, Qing Qiang Zeng, S. Chandrasekhar et al. · 2004 · Journal of Pharmacology and Experimental Therapeutics
60. Association of polymorphisms of the transforming growth factor-ß1 gene with genetic susceptibility to osteoporosis
    Yoshiji Yamada · 2001 · Pharmacogenetics
61. Vitamin D and Osteoclastogenesis
    Hisataka Yasuda, Kanji Higashio, Tatsuo Suda · 2005 · Elsevier eBooks
62. Antiresorptive agents and osteoclast apoptosis
    Paula H. Stern · 2007 · Journal of Cellular Biochemistry
63. Platelet‐rich plasma suppresses osteoclastogenesis by promoting the secretion of osteoprotegerin
    Yoichiro Ogino, Yasunori Ayukawa, Toshio Kukita, Ikiru Atsuta, Kiyoshi Koyano · 2008 · Journal of Periodontal Research
64. Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor kappa B ligand gene in osteoblasts and bone marrow stromal cells
    Jianzhong Liu, Hongmei Yang, Wei Liu, Xuemei Cao, Xu Feng · 2005 · Journal of Cellular Biochemistry
65. Contributions of matrix metalloproteinases toward Meckel’s cartilage resorption in mice: immunohistochemical studies, including comparisons with developing endochondral bones
    Yasunori Sakakura, Yoichiro Hosokawa, Eichi Tsuruga, Kazuharu Irie, Masanori Nakamura, Toshihiko Yajima · 2006 · Cell and Tissue Research
66. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone
    Han, Ki Ok, Choi, Jong Tae, Choi, Hyun Ah, Moon, In Gul, Yim, Chang Hoon, Park, Won Keun, Yoon, Hyun Koo, Han, In Kwon · 2005 · Clinical Endocrinology
67. Effects of Enamel Matrix Derivative on Bone‐Related mRNA Expression in Human Periodontal Ligament Cells In Vitro
    Kazuaki Takayanagi, Ginko Osawa, Hiroshi Nakaya, David Lee Cochran, Kyuich Kamoi, Thomas W. Oates · 2006 · Journal of Periodontology
68. Identification of signal transduction pathways and promoter sequences that mediate parathyroid hormone 1–38 inhibition of osteoprotegerin gene expression
    David Halladay, Rebecca R. Miles, Kannan Thirunavukkarasu, Srinivasan Chandrasekhar, T. John Martin, Jude E. Onyia · 2001 · Journal of Cellular Biochemistry
69. Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor
    Kazuki Yano, Nobuaki Nakagawa, Hisataka Yasuda, Eisuke Tsuda, Kanji Higashio · 2001 · Journal of Bone and Mineral Metabolism
70. Vector-averaged gravity regulates gene expression of receptor activator of NF-κB (RANK) ligand and osteoprotegerin in bone marrow stromal cells via cyclic AMP/protein kinase A pathway
    Kanematsu, M, Yoshimura, K, Takaoki, M, Sato, A · 2002 · Bone
71. Response of preosteoblasts to thermal stress conditioning and osteoinductive growth factors
    Eunna Chung, Marissa Nichole Rylander · 2011 · Cell Stress and Chaperones
72. Osteoprotegerin is expressed in colon carcinoma cells.
    Ingvild Pettersen, Wenche H. Bakkelund, Bård H. Smedsrød, Baldur Sveinbjørnsson · 2005 · PubMed
73. Suppressive effect of Kanzo-bushi-to, a Kampo medicine, on collagen-induced arthritis.
    Y. Ono, M. Inoue, H. Mizukami, Y. Ogihara · 2004 · Biological and Pharmaceutical Bulletin
74. Sensitivity analysis of a novel mathematical model identifies factors determining bone resorption rates
    Marion J. Martin, J. C. Buckland‐Wright · 2004 · Bone
75. Unique Distal Enhancers Linked to the Mouse Tnfsf11 Gene Direct Tissue-Specific and Inflammation-Induced Expression of RANKL
    Melda Onal, Hillary C. St. John, Allison L Danielson, Jaines Markert, Erin M. Riley, John Wesley Pike · 2015 · Endocrinology
76. Anabolic effects of a G protein–coupled receptor kinase inhibitor expressed in osteoblasts
    Robert F. Spurney, Patrick J. Flannery, Sanford C. Garner, Krairerk Athirakul, Shiguang Liu, Farshid Guilak, L. Darryl Quarles · 2002 · Journal of Clinical Investigation
77. Nitric Oxide Donor Increases Osteoprotegerin Production and Osteoclastogenesis Inhibitory Activity in Bone Marrow Stromal Cells from Ovariectomized Rats
    Wang, Feng-Sheng, Wang, Ching-Jen, Chen, Yeung-Jen, Huang, Yu-Ting, Huang, Hui-Chen, Chang, Per-Rong, Sun, Yi-Chih, Yang, Kuender D. · 2004 · Endocrinology
78. Aberrant expression of transforming growth factor β‐1 (TGFβ‐1) per se does not discriminate fibrotic from non‐fibrotic chronic myeloproliferative disorders
    Oliver Bock, Gero Loch, Ulrika M. Schade, Reinhard von Wasielewski, Jérôme Schlué, Hans Heinrich Kreipe · 2005 · The Journal of Pathology
79. SPARC stimulates the synthesis of OPG/OCIF, MMP‐2 and DNA in human periodontal ligament cells
    Tsuyoshi Fujita, Hideki Shiba, Masatoshi Sakata, Yuushi Uchida, Shigeo Nakamura, Hidemi Kurihara · 2002 · Journal of Oral Pathology and Medicine
80. Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes
    Kouichiro Shinoda, Eiji Sugiyama, Hirofumi Taki, S. Harada, Takemine Mino, Muneharu Maruyama, Masashi Kobayashi · 2003 · Bone
81. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG)
    Jen Chin C. Wang, Kirugaval C. Hemavathy, W. Charles, Haowei Zhang, Punkaj K. Dua, Allan D. Novetsky, Tsong S. Chang, Ching Yin Grace Wong, Marlena Jabara · 2004 · Experimental Hematology
82. Strontium inhibits osteoclastogenesis by enhancing LRP6 and β-catenin-mediated OPG targeted by miR-181d-5p
    Tianhao Sun, Zhaoyang Li, Xing Zhong, Zhe Cai, Ziyu Ning, Tianheng Hou, Lifeng Xiong, Yu Feng, Frankie K. L. Leung, William W. Lu et al. · 2018 · Journal of Cell Communication and Signaling
83. Therapeutic Targets of the TNF Superfamily
    Iqbal S. Grewal · 2009 · Advances in experimental medicine and biology
84. Immunology of Osteoporosis: Relevance of Inflammatory Targets for the Development of Novel Interventions
    Syed Sufian Ahmad, Faraha Ahmed, Ruhi Ali, Mohammed M. Ghoneim, Sultan Alshehri, Abul Kalam Najmi, Sayeed Ahmad, Mohammad Zaki Ahmad, Javed Ahmad, Mohammad Ahmed Khan · 2022 · Immunotherapy
85. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor β–mediated down‐regulation of osteoprotegerin
    Hidenori Hase, Yumiko Kanno, Hidefumi Kojima, Daisuke Sakurai, Tetsuji Kobata · 2008 · Arthritis & Rheumatism
86. CD109 Plays a Role in Osteoclastogenesis
    Yongqiang Wang, Maayan Inger, Hongwei Jiang, Howard Charles Tenenbaum, Michael Glogauer · 2013 · PLoS ONE
87. Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice
    Kurt David Hankenson, I JAMES, Stephen Apone, George B. Stroup, Samuel Blake, X.G. Liang, Michael W. Lark, PAUL K. BORNSTEIN · 2005 · Matrix Biology
88. GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults
    Roberto Lanzi, Marco Losa, Isabella Villa, Elisa Gatti, M Sirtori, Chiara Dal Fiume, Alessandro Rubinacci · 2003 · European Journal of Endocrinology
89. The parathyroid hormone, its fragments and analogues - potent bone-builders for treating osteoporosis
    James Whitfield, Paul Morley, Gordon E. Willick · 2000 · Expert Opinion on Investigational Drugs
90. Smad4 is required to inhibit osteoclastogenesis and maintain bone mass
    Mayu Morita, Shigeyuki Yoshida, Ryotaro Iwasaki, Tetsuro Yasui, Yuiko Sato, Tami Kobayashi, Ryuichi Watanabe, Takatsugu Oike, Kana Miyamoto, Masamichi Takami et al. · 2016 · Scientific Reports
91. A comparison of bone quality and its determinants in young opioid-dependent women with healthy control group
    Zenghui Ding, Yanyan Chen, Xi Wang, Xu zhou, Yang Xu, Zuchang Ma, Yining Sun, Ming Jiang · 2017 · Drug and Alcohol Dependence
92. The Role of Cytokines in Orthodontic Tooth Movement
    Hideki Kitaura, Fumitoshi Ohori, Aseel Marahleh, Jinghan Ma, Angyi Lin, Ziqiu Fan, Kohei Narita, Kou Murakami, Hiroyasu Kanetaka · 2025 · International Journal of Molecular Sciences
93. Analysis of the association of polymorphism in the osteoprotegerin gene with susceptibility to chronic kidney disease and periodontitis
    Carla Spagliare Baioni, Cleber Machado Souza, Ana Paula Ribeiro Braosi, Sônia Mara Luczyszyn, Marco Antônio Dias da Silva, S. A. Ignácio, Maria Ângela Naval Machado, Wilson Denis Benato Martins, Miguel Carlos RIELLA, Roberto Pecoits‐Filho et al. · 2008 · Journal of Periodontal Research
94. Prostate‐specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor‐KappaB ligand expression by human osteoblasts
    Hiroyuki Yonou, Yutaka Horiguchi, Yoshio Ohno, Kazunori Namiki, Kunihiko Yoshioka, Makoto Ohori, Tadashi Hatano, Masaaki Tachibana · 2007 · The Prostate
95. Bone growth stimulators New tools for treating bone loss and mending fractures
    James F. Whitfield, Paul Morley, Gordon E. Willick · 2002 · Vitamins and hormones
96. Review of Cathepsin K Inhibitor Development and the Potential Role of Phytochemicals
    Dong‐Oh Moon · 2024 · Molecules
97. The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease
    Pinelopi Grigoropoulou, Ioanna Eleftheriadou, C Zoupas, Nikolaοs Tentolouris · 2011 · Current Medicinal Chemistry
98. Bone morphogenetic proteins regulate osteoprotegerin and its ligands in human vascular smooth muscle cells
    Kirsten Nguyen, Ping Olesen, Thomas Ledet, Lars Melholt Rasmussen · 2007 · Endocrine
99. Bone repair and regeneration
    Nicola Baldini, E. Cenni, Gabriela Ciapetti, Donatella Granchi, L. Savarino · 2009 · Elsevier eBooks
100. Breakthrough in bone: the molecular mechanism of osteoclast/osteoblast coupling revealed
     Edward M. Schwarz, Regis J. O’Keefe · 2000 · Current Opinion in Orthopedics